Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.22 trillion and total revenue of $110.07 billion.
Market Cap
1.22T
Revenue
110.07B
Profits
-40.27B
PE Ratio
n/a
Profit Margin
-36.59%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 122.67B | -1.44% | 1,451,283 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 70.75B | 0.03% | 1,022,112 | 14.92B |
| 3 | ARGX | argenx SE | 55.20B | 1.18% | 227,185 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 38.46B | -1.60% | 2,298,658 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.27B | -0.62% | 1,291,271 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 36.38B | -0.98% | 189,221 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 34.08B | -1.32% | 2,599,404 | 2.44B |
| 8 | INCY | Incyte Corporation | 25.76B | -2.18% | 2,909,557 | 5.82B |
| 9 | ROIV | Roivant Sciences Ltd. | 23.64B | -2.87% | 4,824,299 | 8.26M |
| 10 | BNTX | BioNTech SE | 23.51B | 0.54% | 739,945 | 3.23B |
| 11 | INSM | Insmed Incorporated | 22.35B | -0.97% | 2,195,002 | 819.56M |
| 12 | MRNA | Moderna, Inc. | 21.62B | -2.36% | 4,348,579 | 2.23B |
| 13 | GMAB | Genmab A/S | 17.45B | -1.66% | 1,160,855 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.62B | -0.94% | 507,079 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.38B | -2.35% | 2,400,883 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 16.08B | -0.37% | 622,516 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 13.91B | -2.09% | 1,882,089 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.61B | 1.50% | 356,768 | 1.13B |
| 19 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.14B | 0.51% | 1,807,662 | 622.01M |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.86B | -1.13% | 1,805,383 | 3.24B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.70B | -2.89% | 522,973 | 708.24M |
| 22 | TECH | Bio-Techne Corporation | 11.22B | -0.06% | 6,272,480 | 1.21B |
| 23 | KRYS | Krystal Biotech, Inc. | 10.71B | -0.26% | 355,853 | 417.30M |
| 24 | CYTK | Cytokinetics, Incorporated | 10.64B | -1.34% | 1,527,449 | 105.82M |
| 25 | ABVX | ABIVAX Société Anonyme | 10.63B | -4.34% | 1,146,375 | 5.67M |
| 26 | SMMT | Summit Therapeutics Inc. | 10.21B | 1.99% | 3,777,811 | - |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.02% | 1,084,497 | - |
| 28 | CORT | Corcept Therapeutics Incorporated | 9.98B | -1.32% | 1,520,724 | 769.10M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 9.88B | -0.20% | 1,633,618 | 1.51B |
| 30 | IONS | Ionis Pharmaceuticals, Inc. | 8.93B | -2.28% | 3,128,988 | 873.71M |
| 31 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | 0.02% | 1,621,551 | 18.07M |
| 32 | KYMR | Kymera Therapeutics, Inc. | 8.66B | -0.86% | 505,613 | 51.48M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 8.61B | -2.09% | 1,216,578 | - |
| 34 | PTGX | Protagonist Therapeutics, Inc. | 8.55B | -2.81% | 560,631 | 74.06M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.11B | -1.62% | 339,735 | 7.46M |
| 36 | IMVT | Immunovant, Inc. | 7.97B | -0.75% | 1,620,326 | - |
| 37 | PCVX | Vaxcyte, Inc. | 7.65B | -2.97% | 1,142,192 | - |
| 38 | TGTX | TG Therapeutics, Inc. | 7.58B | -2.53% | 2,916,135 | 700.35M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.30B | -1.40% | 502,052 | 217.17M |
| 40 | IBRX | ImmunityBio, Inc. | 7.15B | -2.01% | 7,709,329 | 140.98M |
| 41 | COGT | Cogent Biosciences, Inc. | 6.76B | -2.70% | 1,220,915 | - |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 6.56B | -4.15% | 682,485 | 569.61M |
| 43 | PTCT | PTC Therapeutics, Inc. | 6.18B | -1.19% | 1,173,843 | 827.11M |
| 44 | ERAS | Erasca, Inc. | 6.15B | -2.42% | 4,191,049 | - |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.10B | -2.83% | 703,481 | 7.50M |
| 46 | CGON | CG Oncology, Inc. | 6.10B | -4.82% | 1,104,142 | 5.07M |
| 47 | BLTE | Belite Bio, Inc | 6.00B | -2.25% | 251,436 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.88B | -0.63% | 1,087,608 | - |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.71B | -2.79% | 292,520 | 274.48M |
| 50 | DNTH | Dianthus Therapeutics, Inc. | 5.69B | 2.44% | 887,299 | 1.34M |
| 51 | DFTX | Definium Therapeutics, Inc. | 5.60B | 0.48% | 1,761,854 | - |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.31B | -2.63% | 790,240 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.17B | -0.63% | 990,979 | 536.20M |
| 54 | CRSP | CRISPR Therapeutics AG | 4.69B | 0.19% | 1,709,077 | 4.10M |
| 55 | DYN | Dyne Therapeutics, Inc. | 4.68B | -3.09% | 2,104,645 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.51B | 1.27% | 1,733,057 | 1.10B |
| 57 | MANE | Veradermics, Incorporated | 4.50B | -3.39% | 446,459 | - |
| 58 | CAI | Caris Life Sciences, Inc. | 4.41B | - | 5,004,048 | 907.29M |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.28B | -1.49% | 698,413 | - |
| 60 | CELC | Celcuity Inc. | 4.06B | 0.97% | 1,371,568 | - |
| 61 | PBLS | Parabilis Medicines, Inc. | 4.05B | -0.56% | 361,137 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.00B | 0.44% | 1,944,064 | 10.68M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.88B | -1.27% | 2,897,345 | - |
| 64 | DNLI | Denali Therapeutics Inc. | 3.79B | -0.83% | 1,375,851 | - |
| 65 | TNGX | Tango Therapeutics, Inc. | 3.74B | -3.00% | 2,209,247 | 56.99M |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.70B | -1.47% | 853,982 | - |
| 67 | LEGN | Legend Biotech Corporation | 3.65B | -1.00% | 2,937,653 | 1.14B |
| 68 | ARQT | Arcutis Biotherapeutics, Inc. | 3.48B | -1.97% | 976,684 | 415.62M |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.41B | -0.88% | 71,976 | 803.79M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 3.38B | -1.58% | 992,820 | 225.27M |
| 71 | GPCR | Structure Therapeutics Inc. | 3.37B | -1.13% | 403,700 | - |
| 72 | ALMS | Alumis Inc. | 3.36B | -2.40% | 820,821 | 8.40M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.33B | -2.22% | 856,151 | 236.00M |
| 74 | NAMS | NewAmsterdam Pharma Company N.V. | 3.26B | -0.25% | 1,301,202 | 22.57M |
| 75 | MBX | MBX Biosciences, Inc. | 3.04B | 6.49% | 564,612 | - |
| 76 | CLDX | Celldex Therapeutics, Inc. | 2.94B | 5.42% | 1,572,690 | 865.00K |
| 77 | IRON | Disc Medicine, Inc. | 2.81B | -1.31% | 358,387 | - |
| 78 | QURE | uniQure N.V. | 2.75B | 9.30% | 3,858,571 | 18.67M |
| 79 | ATAI | AtaiBeckley Inc. | 2.66B | - | 18,599,200 | 3.49M |
| 80 | IMNM | Immunome, Inc. | 2.62B | -0.47% | 793,820 | 4.02M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.59B | -1.03% | 1,577,531 | 164.01M |
| 82 | TRVI | Trevi Therapeutics, Inc. | 2.57B | -1.84% | 1,428,364 | - |
| 83 | TARS | Tarsus Pharmaceuticals, Inc. | 2.52B | -0.73% | 679,675 | 535.08M |
| 84 | KOD | Kodiak Sciences Inc. | 2.50B | -0.69% | 517,566 | - |
| 85 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | -3.77% | 2,326,323 | 670.00M |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.45B | -2.28% | 1,170,106 | 36.77M |
| 87 | NKTR | Nektar Therapeutics | 2.39B | -0.13% | 982,912 | 55.63M |
| 88 | VCEL | Vericel Corporation | 2.38B | -0.19% | 505,444 | 292.09M |
| 89 | VERA | Vera Therapeutics, Inc. | 2.33B | -2.43% | 1,469,000 | - |
| 90 | MLYS | Mineralys Therapeutics, Inc. | 2.32B | -2.23% | 398,610 | - |
| 91 | NUVB | Nuvation Bio Inc. | 2.29B | -1.49% | 6,878,857 | 143.05M |
| 92 | PHVS | Pharvaris N.V. | 2.28B | -3.05% | 372,294 | - |
| 93 | VRDN | Viridian Therapeutics, Inc. | 2.20B | 1.90% | 1,626,181 | 70.92M |
| 94 | KLRA | Kailera Therapeutics, Inc. | 2.19B | 0.84% | 526,524 | - |
| 95 | COAG | Hemab Therapeutics Holdings, Inc. | 2.09B | -5.31% | 517,586 | - |
| 96 | AGIO | Agios Pharmaceuticals, Inc. | 2.08B | -2.72% | 1,155,275 | 66.05M |
| 97 | HRMY | Harmony Biosciences Holdings, Inc. | 2.08B | 0.25% | 467,296 | 899.11M |
| 98 | ZLAB | Zai Lab Limited | 2.06B | -1.66% | 577,608 | 453.28M |
| 99 | PVLA | Palvella Therapeutics, Inc. | 2.05B | -0.17% | 133,993 | - |
| 100 | IOVA | Iovance Biotherapeutics, Inc. | 2.04B | -2.98% | 10,785,662 | 285.61M |
| 101 | SION | Sionna Therapeutics, Inc. | 2.02B | -3.74% | 368,301 | - |
| 102 | BHVN | Biohaven Ltd. | 2.02B | -2.47% | 1,480,118 | - |
| 103 | ADMA | ADMA Biologics, Inc. | 2.02B | -0.91% | 2,185,169 | 509.86M |
| 104 | SLS | SELLAS Life Sciences Group, Inc. | 1.99B | 0.10% | 5,455,208 | - |
| 105 | URGN | UroGen Pharma Ltd. | 1.97B | -1.05% | 317,736 | 140.49M |
| 106 | ZBIO | Zenas BioPharma, Inc. | 1.96B | -3.72% | 625,580 | 10.00M |
| 107 | RAPP | Rapport Therapeutics, Inc. | 1.96B | -2.43% | 322,684 | 20.00M |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | 1.47% | 883,773 | 298.30M |
| 109 | PGEN | Precigen, Inc. | 1.94B | -1.45% | 3,560,689 | 31.60M |
| 110 | FTRE | Fortrea Holdings Inc. | 1.93B | -1.45% | 3,155,494 | 2.68B |
| 111 | GHRS | GH Research PLC | 1.92B | 0.07% | 235,640 | - |
| 112 | NBTX | Nanobiotix S.A. | 1.90B | 0.08% | 176,599 | 38.27M |
| 113 | FBRX | Forte Biosciences, Inc. | 1.87B | -0.16% | 7,249,879 | - |
| 114 | TYRA | Tyra Biosciences, Inc. | 1.85B | 0.74% | 496,078 | - |
| 115 | LKFT | Lakefront Biotherapeutics NV | 1.84B | -1.53% | 255,328 | 1.20B |
| 116 | MESO | Mesoblast Limited | 1.84B | -2.21% | 251,269 | 65.38M |
| 117 | STOK | Stoke Therapeutics, Inc. | 1.84B | 0.31% | 700,137 | 32.08M |
| 118 | OCUL | Ocular Therapeutix, Inc. | 1.83B | -1.07% | 1,566,997 | 52.04M |
| 119 | GLUE | Monte Rosa Therapeutics, Inc. | 1.82B | -2.18% | 921,849 | 42.95M |
| 120 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | 2.75% | 2,699,662 | 7.47M |
| 121 | KARD | Kardigan, Inc. | 1.76B | -6.00% | 162,643 | - |
| 122 | DMRA | Damora Therapeutics, Inc. | 1.74B | -3.70% | 323,117 | - |
| 123 | SNDX | Syndax Pharmaceuticals, Inc. | 1.70B | -2.09% | 1,747,138 | 217.17M |
| 124 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | -3.94% | 1,931,579 | 204.73M |
| 125 | BCAX | Bicara Therapeutics Inc. | 1.70B | -3.68% | 509,359 | - |
| 126 | IMCR | Immunocore Holdings plc | 1.70B | -0.27% | 192,297 | 412.81M |
| 127 | GENB | Generate Biomedicines, Inc. | 1.68B | -0.46% | 747,875 | 30.30M |
| 128 | AAPG | Ascentage Pharma Group International | 1.67B | 0.14% | 4,291 | 82.08M |
| 129 | ABCL | AbCellera Biologics Inc. | 1.65B | 1.89% | 5,777,417 | 79.21M |
| 130 | SRPT | Sarepta Therapeutics, Inc. | 1.64B | 0.68% | 2,397,899 | 2.18B |
| 131 | INVA | Innoviva, Inc. | 1.60B | -0.78% | 536,229 | 420.69M |
| 132 | RXRX | Recursion Pharmaceuticals, Inc. | 1.58B | -2.62% | 17,904,275 | 66.41M |
| 133 | ZYME | Zymeworks Inc. | 1.58B | -2.65% | 340,475 | 81.26M |
| 134 | ANAB | AnaptysBio, Inc. | 1.54B | 0.06% | 428,441 | 232.39M |
| 135 | MLTX | MoonLake Immunotherapeutics | 1.52B | -1.76% | 707,856 | - |
| 136 | SEPN | Septerna, Inc. | 1.51B | -1.06% | 158,215 | 72.26M |
| 137 | MAZE | Maze Therapeutics, Inc. | 1.51B | -2.19% | 309,244 | 20.00M |
| 138 | NTLA | Intellia Therapeutics, Inc. | 1.51B | -0.83% | 3,485,548 | 66.09M |
| 139 | TRAX | First Tracks Biotherapeutics, Inc. | 1.46B | 0.05% | 582,191 | - |
| 140 | VIR | Vir Biotechnology, Inc. | 1.46B | -2.37% | 1,412,788 | 65.50M |
| 141 | XNCR | Xencor, Inc. | 1.45B | -2.20% | 1,161,146 | 97.36M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.40B | 0.20% | 219,493 | - |
| 143 | SVRA | Savara Inc. | 1.34B | -0.94% | 1,259,484 | - |
| 144 | AVLN | Avalyn Pharma Inc. | 1.25B | 1.12% | 112,286 | - |
| 145 | AKTS | Aktis Oncology, Inc. | 1.24B | -2.53% | 314,875 | 8.28M |
| 146 | ARDX | Ardelyx, Inc. | 1.24B | -1.67% | 2,180,280 | 427.68M |
| 147 | MNKD | MannKind Corporation | 1.23B | -1.53% | 3,557,543 | 360.78M |
| 148 | IMTX | Immatics N.V. | 1.23B | 2.92% | 433,921 | 43.00M |
| 149 | NVAX | Novavax, Inc. | 1.21B | -0.41% | 2,324,041 | 596.34M |
| 150 | ABSI | Absci Corporation | 1.17B | -3.23% | 3,491,167 | 1.84M |
| 151 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | -5.29% | 1,844,806 | - |
| 152 | INBX | Inhibrx Biosciences, Inc. | 1.16B | -0.54% | 214,198 | 1.30M |
| 153 | JBIO | Jade Biosciences, Inc. | 1.15B | -1.78% | 633,526 | - |
| 154 | LBRX | LB Pharmaceuticals Inc | 1.12B | 11.62% | 709,074 | - |
| 155 | WVE | Wave Life Sciences Ltd. | 1.12B | -1.36% | 2,298,488 | 71.80M |
| 156 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | -2.03% | 646,671 | - |
| 157 | MGTX | MeiraGTx Holdings plc | 1.08B | -1.69% | 520,237 | 79.76M |
| 158 | VOR | Vor Biopharma Inc. | 1.06B | -2.25% | 862,483 | - |
| 159 | CGEM | Cullinan Therapeutics, Inc. | 1.06B | -1.49% | 544,507 | - |
| 160 | IVA | Inventiva S.A. | 1.06B | -2.80% | 1,176,676 | 7.94M |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.06B | -0.80% | 77,379 | - |
| 162 | ANRO | Alto Neuroscience, Inc. | 1.04B | -2.55% | 300,125 | - |
| 163 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -0.85% | 2,249,588 | 69.64M |
| 164 | DRTS | Alpha Tau Medical Ltd. | 1.01B | -3.20% | 688,559 | - |
| 165 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -2.61% | 789,546 | 59.00K |
| 166 | EYPT | EyePoint, Inc. | 999.39M | -0.33% | 2,053,653 | 7.61M |
| 167 | OLMA | Olema Pharmaceuticals, Inc. | 977.42M | -3.70% | 655,946 | - |
| 168 | SANA | Sana Biotechnology, Inc. | 950.68M | -3.65% | 3,080,249 | - |
| 169 | PHAT | Phathom Pharmaceuticals, Inc. | 924.57M | -0.17% | 728,743 | 204.89M |
| 170 | JANX | Janux Therapeutics, Inc. | 912.33M | -0.27% | 602,866 | 13.73M |
| 171 | GERN | Geron Corporation | 898.13M | -3.45% | 5,655,892 | 196.12M |
| 172 | PHAR | Pharming Group N.V. | 882.92M | -6.61% | 3,224 | 369.49M |
| 173 | TBPH | Theravance Biopharma, Inc. | 873.31M | -0.24% | 444,148 | 109.78M |
| 174 | ODTX | Odyssey Therapeutics, Inc. | 864.20M | -2.06% | 200,542 | 1.06M |
| 175 | ABUS | Arbutus Biopharma Corporation | 847.44M | -2.72% | 2,077,176 | 191.45M |
| 176 | OMER | Omeros Corporation | 844.62M | 3.46% | 1,684,796 | 9.89M |
| 177 | DBVT | DBV Technologies S.A. | 808.24M | 1.70% | 419,988 | 5.04M |
| 178 | ANNX | Annexon, Inc. | 796.27M | -2.21% | 3,463,939 | - |
| 179 | KURA | Kura Oncology, Inc. | 792.76M | -4.08% | 1,787,161 | 71.64M |
| 180 | SLDB | Solid Biosciences Inc. | 791.53M | 0.88% | 904,982 | - |
| 181 | AURA | Aura Biosciences, Inc. | 773.20M | -0.57% | 481,214 | - |
| 182 | TENX | Tenax Therapeutics, Inc. | 757.18M | -6.20% | 1,565,414 | - |
| 183 | DSGN | Design Therapeutics, Inc. | 750.73M | 1.26% | 555,043 | - |
| 184 | FTH | Faeth Therapeutics, Inc. | 744.10M | -0.91% | 260,315 | - |
| 185 | SGP | SpyGlass Pharma, Inc. | 732.52M | 1.34% | 117,116 | - |
| 186 | RIGL | Rigel Pharmaceuticals, Inc. | 722.88M | 1.48% | 223,386 | 299.77M |
| 187 | MNPR | Monopar Therapeutics Inc. | 719.62M | -1.53% | 357,179 | - |
| 188 | ACRS | Aclaris Therapeutics, Inc. | 715.08M | -3.94% | 1,177,962 | 8.37M |
| 189 | DRUG | Bright Minds Biosciences Inc. | 704.79M | -1.25% | 196,804 | - |
| 190 | CLYM | Climb Bio, Inc. | 693.42M | -1.46% | 895,257 | - |
| 191 | CTMX | CytomX Therapeutics, Inc. | 690.12M | -1.55% | 1,132,830 | 35.54M |
| 192 | CADL | Candel Therapeutics, Inc. | 688.74M | -2.89% | 1,441,344 | - |
| 193 | MPLT | MapLight Therapeutics, Inc. | 681.09M | 22.01% | 2,958,886 | - |
| 194 | NGNE | Neurogene Inc. | 670.74M | 1.32% | 132,004 | 925.00K |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 659.68M | -4.13% | 386,773 | - |
| 196 | OCS | Oculis Holding AG | 654.61M | -1.94% | 195,619 | 1.40M |
| 197 | NVCT | Nuvectis Pharma, Inc. | 652.26M | 4.39% | 287,507 | - |
| 198 | ACHV | Achieve Life Sciences, Inc. | 633.92M | -0.08% | 1,279,376 | - |
| 199 | MDXG | MiMedx Group, Inc. | 630.04M | -2.98% | 1,244,999 | 389.42M |
| 200 | GYRE | Gyre Therapeutics, Inc. | 628.80M | -5.84% | 66,082 | 117.05M |
| 201 | ALLO | Allogene Therapeutics, Inc. | 624.73M | 9.04% | 12,490,981 | 22.00K |
| 202 | AGMB | AgomAb Therapeutics NV | 610.67M | -1.12% | 46,769 | - |
| 203 | CBIO | Crescent Biopharma, Inc. | 610.35M | -10.16% | 526,054 | 11.88M |
| 204 | RGNX | REGENXBIO Inc. | 593.58M | 0.21% | 951,722 | 87.82M |
| 205 | IMMX | Immix Biopharma, Inc. | 581.62M | -3.20% | 1,367,475 | - |
| 206 | SPRY | ARS Pharmaceuticals, Inc. | 579.93M | 2.82% | 6,438,188 | 98.99M |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 578.15M | 0.51% | 1,042,573 | 122.29M |
| 208 | ALT | Altimmune, Inc. | 567.86M | -2.34% | 8,001,067 | 36.00K |
| 209 | CRMD | CorMedix Inc. | 564.07M | -2.18% | 1,362,178 | 400.05M |
| 210 | PRME | Prime Medicine, Inc. | 547.27M | -1.94% | 2,195,183 | 4.03M |
| 211 | SLN | Silence Therapeutics plc | 545.55M | - | 595,005 | 839.00K |
| 212 | RLMD | Relmada Therapeutics, Inc. | 539.14M | -1.72% | 1,218,693 | - |
| 213 | CTNM | Contineum Therapeutics, Inc. | 537.62M | 1.55% | 171,219 | - |
| 214 | TECX | Tectonic Therapeutic, Inc. | 536.45M | -4.60% | 165,220 | - |
| 215 | ARVN | Arvinas, Inc. | 530.36M | 0.24% | 740,473 | 89.40M |
| 216 | VSTM | Verastem, Inc. | 528.12M | -3.53% | 2,249,708 | 49.59M |
| 217 | STTK | Shattuck Labs, Inc. | 518.36M | -0.88% | 629,109 | 1.00M |
| 218 | ZURA | Zura Bio Limited | 504.44M | -4.15% | 422,949 | - |
| 219 | FDMT | 4D Molecular Therapeutics, Inc. | 502.37M | -2.44% | 529,744 | 88.24M |
| 220 | DNA | Ginkgo Bioworks Holdings, Inc. | 497.77M | -1.04% | 684,738 | 151.40M |
| 221 | RZLT | Rezolute, Inc. | 490.99M | -4.47% | 802,091 | - |
| 222 | HELP | Cybin Inc. | 490.29M | 4.08% | 1,822,380 | - |
| 223 | EIKN | Eikon Therapeutics, Inc. | 487.79M | -5.06% | 247,113 | - |
| 224 | ARTV | Artiva Biotherapeutics, Inc. | 486.85M | -4.84% | 392,654 | 251.00K |
| 225 | ANL | Adlai Nortye Ltd. | 484.40M | -4.57% | 86,164 | 5.00M |
| 226 | ASMB | Assembly Biosciences, Inc. | 483.39M | -1.80% | 153,276 | 71.10M |
| 227 | VALN | Valneva SE | 475.90M | 0.20% | 8,957 | 180.25M |
| 228 | PRLD | Prelude Therapeutics Incorporated | 467.13M | 1.51% | 485,316 | 16.72M |
| 229 | PROK | ProKidney Corp. | 465.17M | - | 581,108 | 889.00K |
| 230 | REPL | Replimune Group, Inc. | 454.25M | 1.12% | 13,798,101 | - |
| 231 | PRTA | Prothena Corporation plc | 448.14M | - | 641,212 | 57.94M |
| 232 | SGMT | Sagimet Biosciences Inc. | 434.73M | -3.16% | 465,041 | - |
| 233 | IKT | Inhibikase Therapeutics, Inc. | 431.88M | -4.33% | 684,819 | 1.00 |
| 234 | KYTX | Kyverna Therapeutics, Inc. | 429.82M | -5.61% | 1,060,825 | - |
| 235 | OVID | Ovid Therapeutics Inc. | 427.41M | -2.97% | 647,335 | 7.12M |
| 236 | CABA | Cabaletta Bio, Inc. | 427.20M | -4.03% | 2,010,925 | - |
| 237 | SLBT | SL Science Holding Limited | 420.23M | -5.45% | 57,003 | 3.36M |
| 238 | BNTC | Benitec Biopharma Inc. | 413.97M | 1.35% | 27,581 | - |
| 239 | OCGN | Ocugen, Inc. | 402.84M | -4.03% | 6,951,491 | 4.47M |
| 240 | EDIT | Editas Medicine, Inc. | 399.00M | -0.76% | 1,406,707 | 38.69M |
| 241 | EVMN | Evommune, Inc. | 398.00M | -1.78% | 307,854 | 10.00M |
| 242 | PBYI | Puma Biotechnology, Inc. | 397.52M | -2.01% | 200,258 | 227.18M |
| 243 | EPRX | Eupraxia Pharmaceuticals Inc. | 396.40M | -2.13% | 783,152 | - |
| 244 | VTVT | vTv Therapeutics Inc. | 390.65M | 1.29% | 215,414 | 36.84M |
| 245 | CCCC | C4 Therapeutics, Inc. | 389.20M | -0.85% | 2,099,994 | 34.86M |
| 246 | AUTL | Autolus Therapeutics plc | 388.57M | 0.69% | 632,662 | 92.62M |
| 247 | STRO | Sutro Biopharma, Inc. | 386.42M | -1.73% | 187,182 | 99.61M |
| 248 | CAPR | Capricor Therapeutics, Inc. | 386.27M | 1.52% | 27,501 | 11.13M |
| 249 | LRMR | Larimar Therapeutics, Inc. | 378.91M | -5.22% | 1,795,070 | - |
| 250 | XFOR | X4 Pharmaceuticals, Inc. | 377.28M | 1.78% | 875,592 | 9.01M |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 369.73M | 2.44% | 833,768 | - |
| 252 | IPSC | Century Therapeutics, Inc. | 364.32M | -1.46% | 1,057,775 | 109.16M |
| 253 | ENTA | Enanta Pharmaceuticals, Inc. | 362.03M | -1.27% | 147,298 | 69.21M |
| 254 | ABEO | Abeona Therapeutics Inc. | 355.08M | 3.49% | 1,708,475 | 14.54M |
| 255 | CMPX | Compass Therapeutics, Inc. | 349.37M | -4.90% | 2,934,324 | 850.00K |
| 256 | UPB | Upstream Bio, Inc. | 348.83M | 0.16% | 702,775 | 3.32M |
| 257 | SCTX | Scribe Therapeutics Inc. | 346.35M | 1.66% | 325,000 | 36.28M |
| 258 | RCKT | Rocket Pharmaceuticals, Inc. | 342.87M | - | 1,123,355 | - |
| 259 | DMAC | DiaMedica Therapeutics Inc. | 340.54M | -4.82% | 283,142 | - |
| 260 | PALI | Palisade Bio, Inc. | 340.22M | -2.97% | 1,658,902 | - |
| 261 | LXEO | Lexeo Therapeutics, Inc. | 338.43M | -1.82% | 848,644 | - |
| 262 | FENC | Fennec Pharmaceuticals Inc. | 335.21M | -2.92% | 100,595 | 51.00M |
| 263 | CUVL | Clinuvel Pharmaceuticals Limited | 334.95M | -2.64% | 29,993 | 64.24M |
| 264 | ZNTL | Zentalis Pharmaceuticals, Inc. | 332.44M | 1.08% | 709,425 | 26.87M |
| 265 | LYEL | Lyell Immunopharma, Inc. | 317.82M | -0.15% | 198,891 | 31.00K |
| 266 | VCRE | Vicore Pharma Holding AB (publ) | 313.19M | -2.22% | 1,525 | 370.61K |
| 267 | NMRA | Neumora Therapeutics, Inc. | 305.72M | -1.79% | 666,815 | - |
| 268 | VNDA | Vanda Pharmaceuticals Inc. | 303.68M | -2.13% | 663,164 | 217.78M |
| 269 | AGEN | Agenus Inc. | 296.71M | 0.45% | 1,845,724 | 123.87M |
| 270 | IRD | Opus Genetics, Inc. | 286.50M | 1.76% | 896,598 | 11.98M |
| 271 | OABI | OmniAb, Inc. | 282.70M | -1.02% | 292,652 | 28.94M |
| 272 | FHTX | Foghorn Therapeutics Inc. | 278.30M | -7.60% | 200,520 | 28.22M |
| 273 | FATE | Fate Therapeutics, Inc. | 275.08M | 1.72% | 1,075,159 | 6.32M |
| 274 | SLGL | Sol-Gel Technologies Ltd. | 269.84M | -0.63% | 54,344 | 18.47M |
| 275 | BCYC | Bicycle Therapeutics plc | 269.47M | -2.03% | 341,151 | 63.50M |
| 276 | SABS | SAB Biotherapeutics, Inc. | 266.10M | 0.87% | 371,278 | 114.70K |
| 277 | LCTX | Lineage Cell Therapeutics, Inc. | 264.26M | -0.93% | 1,363,707 | 14.78M |
| 278 | IMRX | Immuneering Corporation | 262.35M | -4.36% | 801,047 | - |
| 279 | ALXO | ALX Oncology Holdings Inc. | 261.72M | -2.26% | 444,802 | - |
| 280 | NAGE | Niagen Bioscience, Inc. | 256.99M | -2.13% | 811,726 | 130.42M |
| 281 | ELDN | Eledon Pharmaceuticals, Inc. | 255.87M | -2.65% | 1,068,901 | - |
| 282 | QTTB | Q32 Bio Inc. | 248.24M | -6.81% | 720,022 | 53.74M |
| 283 | ADAG | Adagene Inc. | 245.79M | -0.27% | 410,279 | 7.67M |
| 284 | PRQR | ProQR Therapeutics N.V. | 244.14M | -1.70% | 310,403 | 15.73M |
| 285 | IFRX | InflaRx N.V. | 243.03M | -2.37% | 906,671 | 33.82K |
| 286 | FULC | Fulcrum Therapeutics, Inc. | 241.21M | -2.69% | 1,112,777 | 80.00M |
| 287 | TRDA | Entrada Therapeutics, Inc. | 236.02M | 12.35% | 435,421 | 5.74M |
| 288 | MGNX | MacroGenics, Inc. | 233.28M | -4.68% | 413,988 | 157.08M |
| 289 | AVXL | Anavex Life Sciences Corp. | 230.75M | -3.11% | 1,099,646 | - |
| 290 | GALT | Galectin Therapeutics Inc. | 229.84M | 2.95% | 330,534 | - |
| 291 | OBIO | Orchestra BioMed Holdings, Inc. | 227.55M | -1.55% | 256,023 | 32.72M |
| 292 | ACIU | AC Immune SA | 225.19M | -2.16% | 61,273 | 4.62M |
| 293 | SRZN | Surrozen, Inc. | 222.92M | -1.03% | 313,868 | 7.49M |
| 294 | TTRX | Turn Therapeutics Inc. | 221.33M | -3.51% | 72,689 | - |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 218.01M | -3.01% | 168,818 | 1.78M |
| 296 | CHRS | Coherus Oncology, Inc. | 217.49M | -2.08% | 570,797 | 46.88M |
| 297 | TARA | Protara Therapeutics, Inc. | 214.14M | -3.30% | 652,758 | - |
| 298 | CGEN | Compugen Ltd. | 211.87M | -0.88% | 198,239 | 72.66M |
| 299 | CNXU | Conexeu Sciences Inc. | 211.12M | 1.28% | 122,386 | - |
| 300 | CLLS | Cellectis S.A. | 208.21M | 0.70% | 9,517 | 75.11M |
| 301 | INDP | Indaptus Therapeutics, Inc. | 206.10M | 5.20% | 173,049 | - |
| 302 | KROS | Keros Therapeutics, Inc. | 197.32M | -0.99% | 164,274 | 33.18M |
| 303 | WHWK | Whitehawk Therapeutics, Inc. | 196.85M | -0.54% | 718,536 | 7.15M |
| 304 | ACOG | Alpha Cognition Inc. | 191.61M | 4.64% | 27,333 | 10.83M |
| 305 | RNA | Atrium Therapeutics, Inc. | 191.24M | -2.70% | 119,405 | 36.68M |
| 306 | NERV | Minerva Neurosciences, Inc. | 190.55M | -4.44% | 163,497 | - |
| 307 | GLSI | Greenwich LifeSciences, Inc. | 187.88M | -4.83% | 102,013 | - |
| 308 | OTLK | Outlook Therapeutics, Inc. | 187.00M | 10.62% | 28,184,592 | 333.14K |
| 309 | NBP | NovaBridge Biosciences | 186.19M | -8.00% | 296,597 | - |
| 310 | PYXS | Pyxis Oncology, Inc. | 185.00M | 0.34% | 943,052 | 13.86M |
| 311 | MDWD | MediWound Ltd. | 184.43M | -1.85% | 76,340 | 14.48M |
| 312 | PLX | Protalix BioTherapeutics, Inc. | 182.90M | -2.58% | 577,962 | 76.38M |
| 313 | VYGR | Voyager Therapeutics, Inc. | 181.26M | -1.32% | 588,418 | 36.49M |
| 314 | ANTX | AN2 Therapeutics, Inc. | 180.80M | 6.81% | 180,990 | - |
| 315 | LENZ | LENZ Therapeutics, Inc. | 179.35M | -2.72% | 722,561 | 20.99M |
| 316 | DTIL | Precision BioSciences, Inc. | 177.78M | -3.91% | 301,618 | 45.07M |
| 317 | IMUX | Immunic, Inc. | 177.76M | -2.17% | 92,039 | - |
| 318 | CAMP | Camp4 Therapeutics Corporation | 169.80M | -4.39% | 92,767 | 3.93M |
| 319 | NGEN | NervGen Pharma Corp. | 169.20M | -1.24% | 346,559 | - |
| 320 | ALEC | Alector, Inc. | 168.76M | - | 307,858 | 18.42M |
| 321 | IPHA | Innate Pharma S.A. | 168.67M | 8.31% | 992 | 10.57M |
| 322 | HUMA | Humacyte, Inc. | 168.42M | -0.97% | 3,760,341 | 2.02M |
| 323 | ARMP | Armata Pharmaceuticals, Inc. | 167.77M | -3.38% | 97,489 | 5.20M |
| 324 | MENS | Jyong Biotech Ltd. | 166.28M | -6.28% | 69,884 | - |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 165.27M | -1.82% | 263,489 | - |
| 326 | ARCT | Arcturus Therapeutics Holdings Inc. | 164.57M | 0.70% | 344,715 | 54.71M |
| 327 | ORMP | Oramed Pharmaceuticals Inc. | 162.48M | -4.80% | 130,651 | 2.00M |
| 328 | IVVD | Invivyd, Inc. | 159.97M | -8.48% | 3,844,111 | 55.87M |
| 329 | OKUR | OnKure Therapeutics, Inc. | 159.56M | - | 82,488 | - |
| 330 | YDES | YD Bio Limited | 159.56M | -1.35% | 14,584 | 510.36K |
| 331 | TNYA | Tenaya Therapeutics, Inc. | 159.52M | -2.78% | 1,531,959 | 225.00K |
| 332 | KPTI | Karyopharm Therapeutics Inc. | 155.47M | -3.24% | 436,849 | 151.12M |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 152.40M | -7.46% | 483,015 | - |
| 334 | NKTX | Nkarta, Inc. | 152.39M | -4.05% | 634,670 | - |
| 335 | TNXP | Tonix Pharmaceuticals Holding Corp. | 151.60M | -4.33% | 543,021 | 17.56M |
| 336 | CNTN | Canton Strategic Holdings, Inc. | 148.85M | -5.39% | 1,188,121 | - |
| 337 | MOLN | Molecular Partners AG | 148.64M | 2.60% | 299 | 856.30K |
| 338 | CBUS | Cibus, Inc. | 148.08M | - | 202,244 | 4.29M |
| 339 | ENTX | Entera Bio Ltd. | 147.87M | -7.98% | 1,554,136 | 42.00K |
| 340 | CRBU | Caribou Biosciences, Inc. | 145.80M | -1.34% | 1,300,406 | 11.20M |
| 341 | KRRO | Korro Bio, Inc. | 145.24M | -4.10% | 132,331 | 3.84M |
| 342 | EQ | Equillium, Inc. | 144.16M | -1.72% | 380,868 | 4.39M |
| 343 | MIST | Milestone Pharmaceuticals Inc. | 141.49M | -2.80% | 2,224,037 | 1.78M |
| 344 | KZIA | Kazia Therapeutics Limited | 137.47M | -5.20% | 162,213 | 1.27M |
| 345 | NRXP | NRx Pharmaceuticals, Inc. | 135.37M | -8.76% | 728,058 | 2.29M |
| 346 | CDXS | Codexis, Inc. | 133.62M | -2.00% | 1,007,798 | 78.09M |
| 347 | NAUT | Nautilus Biotechnology, Inc. | 132.35M | -13.33% | 1,686,411 | 190.00K |
| 348 | HURA | TuHURA Biosciences, Inc. | 129.91M | -4.23% | 236,177 | - |
| 349 | UNCY | Unicycive Therapeutics, Inc. | 129.84M | -4.05% | 1,555,858 | - |
| 350 | CNTB | Connect Biopharma Holdings Limited | 129.08M | -1.44% | 154,391 | 233.00K |
| 351 | PMN | ProMIS Neurosciences, Inc. | 126.09M | -3.17% | 262,603 | - |
| 352 | GNLX | Genelux Corporation | 125.68M | -3.08% | 125,501 | 8.00K |
| 353 | TLSA | Tiziana Life Sciences Ltd | 123.98M | -0.87% | 11,532 | - |
| 354 | ENGN | enGene Therapeutics Inc. | 119.91M | 1.70% | 559,027 | - |
| 355 | ANIX | Anixa Biosciences, Inc. | 118.40M | -1.14% | 169,631 | - |
| 356 | PEPG | PepGen Inc. | 118.28M | -6.56% | 929,860 | - |
| 357 | CUE | Cue Biopharma, Inc. | 117.65M | -7.40% | 100,571 | 32.73M |
| 358 | AARD | Aardvark Therapeutics, Inc. | 116.06M | -17.13% | 174,269 | - |
| 359 | RANI | Rani Therapeutics Holdings, Inc. | 115.07M | 3.00% | 701,844 | 3.17M |
| 360 | SEER | Seer, Inc. | 114.36M | -2.80% | 1,829,149 | 15.17M |
| 361 | SPRB | Spruce Biosciences, Inc. | 114.08M | -0.36% | 44,617 | 697.00K |
| 362 | FBIO | Fortress Biotech, Inc. | 111.28M | -1.18% | 324,755 | 66.16M |
| 363 | GUTS | Fractyl Health, Inc. | 109.47M | -4.51% | 1,241,013 | 3.00K |
| 364 | VANI | Vivani Medical, Inc. | 108.66M | -3.82% | 85,016 | - |
| 365 | GOSS | Gossamer Bio, Inc. | 101.04M | 0.78% | 29,810,636 | 55.54M |
| 366 | ICCC | ImmuCell Corporation | 99.61M | -2.05% | 25,244 | 29.93M |
| 367 | ALDX | Aldeyra Therapeutics, Inc. | 97.12M | 1.90% | 745,429 | - |
| 368 | BDTX | Black Diamond Therapeutics, Inc. | 95.12M | -5.68% | 869,399 | 70.00M |
| 369 | PLYX | Polaryx Therapeutics, Inc. | 94.21M | - | 155,295 | - |
| 370 | HRTX | Heron Therapeutics, Inc. | 93.41M | 1.56% | 1,500,638 | 150.71M |
| 371 | COYA | Coya Therapeutics, Inc. | 90.78M | -3.25% | 144,263 | 7.94M |
| 372 | NTHI | NeOnc Technologies Holdings, Inc. | 90.77M | 0.29% | 21,141 | 39.99K |
| 373 | ONCY | Oncolytics Biotech Inc. | 89.71M | -5.11% | 889,756 | - |
| 374 | PTHS | Pelthos Therapeutics Inc. | 89.46M | -7.31% | 72,326 | 27.70M |
| 375 | VRCA | Verrica Pharmaceuticals Inc. | 88.99M | -4.07% | 24,808 | 37.16M |
| 376 | BMEA | Biomea Fusion, Inc. | 88.21M | -2.40% | 360,607 | - |
| 377 | ACET | Adicet Bio, Inc. | 87.16M | 1.22% | 92,129 | - |
| 378 | OKYO | OKYO Pharma Limited | 86.07M | - | 124,973 | - |
| 379 | INO | Inovio Pharmaceuticals, Inc. | 85.56M | 0.97% | 1,739,144 | 65.34K |
| 380 | YARW | Yarrow Bioscience, Inc. | 85.26M | 8.56% | 15,827 | - |
| 381 | RLYB | Rallybio Corporation | 84.56M | -1.21% | 16,360 | 858.00K |
| 382 | TELO | Telomir Pharmaceuticals, Inc. | 83.22M | 2.54% | 88,076 | - |
| 383 | KLRS | Kalaris Therapeutics, Inc. | 80.89M | 1.80% | 100,016 | - |
| 384 | CGTX | Cognition Therapeutics, Inc. | 80.65M | -2.43% | 330,878 | - |
| 385 | PYPD | PolyPid Ltd. | 78.23M | 8.80% | 435,220 | - |
| 386 | ATHE | Alterity Therapeutics Limited | 77.40M | -2.74% | 2,146 | 4.43M |
| 387 | CSBR | Champions Oncology, Inc. | 75.86M | -1.27% | 11,529 | 59.43M |
| 388 | NRXS | NeurAxis, Inc. | 74.80M | -7.50% | 164,347 | 4.28M |
| 389 | ALPS | Alps Group Inc | 73.22M | -5.46% | 1,714 | 3.74M |
| 390 | MAIA | MAIA Biotechnology, Inc. | 72.96M | -3.23% | 499,638 | - |
| 391 | ATRA | Atara Biotherapeutics, Inc. | 72.62M | 3.20% | 39,846 | 23.14M |
| 392 | ANVS | Annovis Bio, Inc. | 72.32M | 0.59% | 567,781 | - |
| 393 | GANX | Gain Therapeutics, Inc. | 72.09M | -2.31% | 536,519 | - |
| 394 | RNTX | Rein Therapeutics Inc. | 70.52M | -3.04% | 215,162 | - |
| 395 | SPRO | Spero Therapeutics, Inc. | 68.90M | -0.42% | 1,035,743 | 61.19M |
| 396 | XBIT | XBiotech Inc. | 68.60M | -0.88% | 35,558 | - |
| 397 | ELTX | Elicio Therapeutics, Inc. | 67.78M | -2.03% | 259,807 | - |
| 398 | IBIO | iBio, Inc. | 67.56M | -2.16% | 802,748 | 300.00K |
| 399 | LONA | LeonaBio, Inc. | 66.13M | 1.00% | 14,638 | - |
| 400 | OSTX | OS Therapies Incorporated | 65.92M | -1.33% | 228,340 | - |
| 401 | PLRX | Pliant Therapeutics, Inc. | 65.02M | -1.87% | 228,679 | - |
| 402 | IMA | ImageneBio, Inc. | 64.29M | -1.04% | 25,346 | 800.00K |
| 403 | MNOV | MediciNova, Inc. | 63.50M | -3.01% | 7,838 | 596.64K |
| 404 | ACRV | Acrivon Therapeutics, Inc. | 61.21M | -7.14% | 766,037 | - |
| 405 | CING | Cingulate Inc. | 60.95M | -0.11% | 125,051 | - |
| 406 | HYFT | MindWalk Holdings Corp. | 60.73M | -4.41% | 189,391 | 11.43M |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 57.06M | -2.73% | 374,856 | - |
| 408 | CNTX | Context Therapeutics Inc. | 56.69M | 4.47% | 1,201,137 | - |
| 409 | BOLD | Boundless Bio, Inc. | 55.71M | 0.40% | 71,713 | - |
| 410 | CRDF | Cardiff Oncology, Inc. | 55.38M | -0.98% | 1,201,993 | 525.00K |
| 411 | XLO | Xilio Therapeutics, Inc. | 54.44M | -0.55% | 12,036 | 53.48M |
| 412 | DWTX | Dogwood Therapeutics, Inc. | 51.79M | -0.65% | 67,113 | - |
| 413 | INKT | MiNK Therapeutics, Inc. | 51.71M | -1.52% | 7,293 | - |
| 414 | VRXA | Veraxa Biotech AG | 49.68M | -0.51% | 177,943 | - |
| 415 | ELOX | Eloxx Pharmaceuticals, Inc. | 49.40M | -4.45% | 53,532 | - |
| 416 | TIL | Instil Bio, Inc. | 48.97M | -0.96% | 5,349 | - |
| 417 | MREO | Mereo BioPharma Group plc | 48.92M | -0.94% | 1,485,240 | 500.00K |
| 418 | TCRX | TScan Therapeutics, Inc. | 48.46M | -4.19% | 609,443 | 9.14M |
| 419 | IMMP | Immutep Limited | 48.33M | -1.53% | 184,629 | 5.28M |
| 420 | EDSA | Edesa Biotech, Inc. | 47.66M | 7.85% | 128,355 | - |
| 421 | ATYR | aTyr Pharma, Inc. | 47.36M | -2.23% | 593,458 | 190.00K |
| 422 | BYSI | BeyondSpring Inc. | 47.29M | -2.95% | 6,622 | 1.88M |
| 423 | IBO | Impact BioMedical Inc. | 45.99M | -0.81% | 12,747 | 39.00K |
| 424 | MGX | Metagenomi Therapeutics, Inc. | 45.55M | - | 8,067 | 22.33M |
| 425 | MCRB | Seres Therapeutics, Inc. | 45.03M | -3.12% | 53,052 | 1.15M |
| 426 | INMB | INmune Bio Inc. | 44.93M | -1.17% | 212,327 | 50.00K |
| 427 | FLNA | Filana Therapeutics, Inc. | 42.01M | -1.73% | 241,747 | - |
| 428 | RNXT | RenovoRx, Inc. | 40.50M | -1.01% | 127,619 | 1.49M |
| 429 | DYAI | Dyadic International, Inc. | 38.63M | - | 80,749 | 3.81M |
| 430 | APLM | Apollomics, Inc. | 38.39M | -4.06% | 9,100 | 8.84M |
| 431 | RADX | Radiopharm Theranostics Limited | 38.10M | -4.83% | 83,816 | 10.86M |
| 432 | PDSB | PDS Biotechnology Corporation | 37.37M | -3.04% | 117,060 | - |
| 433 | EXOZ | eXoZymes, Inc. | 37.31M | - | 4,059 | -700.00 |
| 434 | ENLV | Enlivex Ltd. | 36.16M | 0.45% | 373,688 | - |
| 435 | VERU | Veru Inc. | 35.47M | -0.90% | 196,242 | 16.89M |
| 436 | HYPD | Hyperion DeFi, Inc. | 35.47M | -3.31% | 361,624 | 1.04M |
| 437 | NNVC | NanoViricides, Inc. | 35.08M | -4.35% | 160,503 | - |
| 438 | NTRB | Nutriband Inc. | 35.01M | -2.54% | 4,810 | 1.80M |
| 439 | GRCE | Grace Therapeutics, Inc. | 33.85M | -7.56% | 1,356,630 | - |
| 440 | CRVO | CervoMed Inc. | 33.55M | -3.13% | 364,174 | 2.09M |
| 441 | ESLA | Estrella Immunopharma, Inc. | 33.53M | 4.09% | 9,530 | - |
| 442 | LITS | Lite Strategy, Inc. | 32.37M | -1.93% | 86,943 | - |
| 443 | LTRN | Lantern Pharma Inc. | 32.02M | -3.46% | 36,465 | - |
| 444 | SER | Serina Therapeutics, Inc. | 31.04M | - | 1,773 | 130.00K |
| 445 | GNTA | Genenta Science S.p.A. | 30.67M | -17.20% | 90,088 | - |
| 446 | BCTX | BriaCell Therapeutics Corp. | 30.01M | -2.02% | 46,108 | - |
| 447 | KYNB | Kyntra Bio, Inc. | 27.45M | -2.80% | 6,585 | 7.44M |
| 448 | ALGS | Aligos Therapeutics, Inc. | 26.30M | - | 46,182 | 4.71M |
| 449 | ATNM | Actinium Pharmaceuticals, Inc. | 26.26M | -3.42% | 80,795 | 90.00K |
| 450 | ACTU | Actuate Therapeutics, Inc. | 25.84M | 1.89% | 59,229 | - |
| 451 | ABVC | ABVC BioPharma, Inc. | 25.52M | -4.72% | 44,968 | 797.92K |
| 452 | TVGN | Tevogen Bio Holdings Inc. | 25.06M | 6.26% | 12,390 | - |
| 453 | PSTV | Plus Therapeutics, Inc. | 24.99M | -3.46% | 93,719 | 5.18M |
| 454 | IGC | IGC Pharma, Inc. | 24.02M | -7.34% | 1,040,213 | 1.11M |
| 455 | EVAX | Evaxion A/S | 23.69M | 1.43% | 13,406 | 7.53M |
| 456 | BRNS | Barinthus Biotherapeutics plc | 23.44M | 0.65% | 15,477 | 14.97M |
| 457 | HOWL | Werewolf Therapeutics, Inc. | 22.35M | 2.38% | 967,224 | 1.14M |
| 458 | PLRZ | Polyrizon Ltd. | 21.90M | 3.91% | 51,960 | - |
| 459 | SKYE | Skye Bioscience, Inc. | 21.61M | 0.02% | 96,754 | - |
| 460 | QNCX | Quince Therapeutics, Inc. | 21.52M | 13.58% | 80,225 | - |
| 461 | NEUP | Neuphoria Therapeutics Inc. | 20.54M | -0.26% | 81,140 | -13.27K |
| 462 | TVRD | Tvardi Therapeutics, Inc. | 20.08M | -12.30% | 609,187 | - |
| 463 | CVM | CEL-SCI Corporation | 19.92M | -5.00% | 143,788 | - |
| 464 | ATOS | Atossa Therapeutics, Inc. | 19.89M | -4.35% | 40,537 | - |
| 465 | CLRB | Cellectar Biosciences, Inc. | 19.82M | -0.80% | 84,970 | - |
| 466 | CELU | Celularity Inc. | 19.40M | -11.84% | 237,243 | 26.55M |
| 467 | QNTM | Quantum BioPharma Ltd. | 18.98M | -5.67% | 91,472 | - |
| 468 | NCEL | NewcelX Ltd. | 18.95M | 1.15% | 9,551 | - |
| 469 | LGVN | Longeveron Inc. | 18.80M | -1.05% | 171,751 | 1.22M |
| 470 | MRKR | Marker Therapeutics, Inc. | 18.51M | -5.93% | 39,202 | 3.55M |
| 471 | ALLR | Allarity Therapeutics, Inc. | 18.46M | -1.69% | 55,403 | 345.00K |
| 472 | NXTC | NextCure, Inc. | 18.13M | -7.38% | 355,456 | - |
| 473 | DARE | Daré Bioscience, Inc. | 17.38M | -2.11% | 80,535 | 1.16M |
| 474 | GRDX | GridAI Technologies Corp. | 17.30M | -13.04% | 68,287 | - |
| 475 | LPCN | Lipocine Inc. | 17.07M | -3.27% | 38,267 | 2.00M |
| 476 | PLUR | Pluri Inc. | 17.05M | -5.95% | 10,400 | 1.08M |
| 477 | NRSN | NeuroSense Therapeutics Ltd. | 16.97M | -13.99% | 1,031,262 | - |
| 478 | JSPR | Jasper Therapeutics, Inc. | 16.80M | -5.20% | 195,556 | - |
| 479 | OSRH | OSR Health, Inc. | 16.64M | 3.81% | 688,224 | 2.63M |
| 480 | BIOT | Instinct Brothers Co., Ltd. | 16.14M | -57.89% | 5,733,061 | - |
| 481 | CTXR | Citius Pharmaceuticals, Inc. | 15.62M | 14.26% | 1,102,559 | 5.61M |
| 482 | PTN | Palatin Technologies, Inc. | 15.25M | 5.21% | 8,437 | 12.88M |
| 483 | KTTA | Pasithea Therapeutics Corp. | 15.04M | - | 406,370 | - |
| 484 | MLEC | Moolec Science SA | 15.03M | -0.56% | 1,999 | 7.83M |
| 485 | CYCN | Cyclerion Therapeutics, Inc. | 14.84M | - | 10,036 | 1.99M |
| 486 | AKTX | Akari Therapeutics, Plc | 14.44M | -2.14% | 3,519 | - |
| 487 | PASG | Passage Bio, Inc. | 14.34M | -2.19% | 4,420 | - |
| 488 | HIND | Vyome Holdings, Inc. | 13.97M | - | 5,304 | 152.72K |
| 489 | TPST | Tempest Therapeutics, Inc. | 13.21M | 2.46% | 157,336 | - |
| 490 | LEXX | Lexaria Bioscience Corp. | 13.14M | -1.87% | 75,291 | 194.00K |
| 491 | ICU | SeaStar Medical Holding Corporation | 13.07M | -5.52% | 61,519 | 1.44M |
| 492 | BLRX | BioLineRx Ltd. | 12.89M | -2.14% | 1,823 | 1.40M |
| 493 | KALA | KALA BIO, Inc. | 12.52M | 2.00% | 36,636 | - |
| 494 | COCP | Cocrystal Pharma, Inc. | 12.00M | -6.91% | 73,735 | 225.00K |
| 495 | CALC | CalciMedica, Inc. | 11.73M | 3.48% | 289,720 | - |
| 496 | INTS | Intensity Therapeutics, Inc. | 11.70M | -4.84% | 21,554 | - |
| 497 | PHIO | Phio Pharmaceuticals Corp. | 11.43M | -2.55% | 95,026 | - |
| 498 | KPRX | Kiora Pharmaceuticals, Inc. | 11.39M | - | 4,568 | 20.00K |
| 499 | PBM | Psyence Biomedical Ltd. | 11.37M | -5.70% | 17,950 | - |
| 500 | XCUR | Exicure, Inc. | 11.03M | -0.57% | 26,712 | 500.00K |